Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Medicine and Dentistry
Brain Metastasis
100%
Glioblastoma
66%
Cancer Surgery
53%
Neoplasm
48%
Craniotomy
37%
Evofosfamide
33%
Hypoxia
33%
Surgical Infection
33%
Craniopharyngioma
33%
Endometriosis
33%
Metastatic Carcinoma
33%
Sciatic Nerve
33%
Subdural Hematoma
33%
Breast Cancer
33%
Sacituzumab Govitecan
33%
Pleomorphic Xanthoastrocytoma
33%
Anaplastic Carcinoma
33%
Rhabdomyosarcoma
33%
Desmoplastic Fibroma
33%
Tumor Recurrence
33%
Lumbar Spine
33%
Evacuation
33%
Bevacizumab
33%
Triage
33%
Phosphorus 32
33%
Colorectal Carcinoma
33%
Graft Salvage
33%
Bone Graft
33%
Sciatica
33%
Treatment Outcome
33%
Tumor
25%
Cyst
25%
Recurrent Disease
23%
Diseases
21%
Coma Scale
20%
Ganglioglioma
16%
Debridement
16%
Radiation Therapy
16%
Histopathology
16%
Larotrectinib
16%
Molecular Profiling
16%
Targeted Therapy
16%
Pediatrics
16%
Monitor Unit
14%
Pelvis
13%
Midline Shift
13%
Elderly Patient
13%
Overall Survival
12%
Biological Marker
12%
Replantation
11%
Immunology and Microbiology
Bevacizumab
100%
Programmed Cell Death
50%
Magnetic Resonance Imaging
50%
Progression Free Survival
43%
Mouse Model
41%
Overall Survival
40%
Infection
38%
Xenograft
38%
Infectious Disease
38%
Immunotherapy Response
33%
Skull
33%
Nude Rat
33%
Metaphysis
33%
Tumor Hypoxia
33%
Epiphysis
33%
Immunotoxin
33%
Human Immunodeficiency Virus Infection
33%
Lumbar Spine
33%
Perfusion
33%
Nude Mouse
33%
Human Immunodeficiency Virus
33%
Immunotherapy
33%
Sacituzumab Govitecan
33%
Soft Tissue
33%
Coinfection
33%
Vertebra
33%
Tumor Cell
25%
Antiangiogenic Activity
16%
Bioluminescence
16%
Vascularization
16%
Mitochondrion
16%
Transgene
16%
Murine
16%
Glioma Cell
16%
Confocal Microscopy
16%
Caspase
16%
CD31
16%
Promoter Region
16%
Neovascularization (Pathology)
16%
Endothelial Cells
16%
Tumor Vascularization
16%
Human Adenovirus 5
16%
Blood Vessels
16%
Endothelium
16%
Tumor Volume
13%
Drug Megadose
8%
Radioresistance
8%
Glioblastoma Cell Line
8%
STAT3
8%
Cytokine
8%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
91%
Bevacizumab
66%
Evofosfamide
66%
Diseases
41%
Clinical Trial
37%
Lipid
36%
Sacituzumab Govitecan
33%
Brain Metastasis
33%
Rhenium
33%
Astrocytoma
33%
Implant
33%
Rhenium 186
33%
Hypoxia
33%
Breast Cancer
33%
Adverse Event
28%
Progression Free Survival
28%
Maximum Tolerated Dose
22%
Neoplasm
22%
Intracranial Tumor
18%
Overall Survival
15%
Drug Release
13%
Macrogol
13%
Tolerability
11%
Biological Marker
7%
Paracetamol
6%
Acetylsalicylic Acid
6%
Glycerol Behenate
6%
Sustained Release
6%
Monotherapy
6%
